Ozempic-Maker Novo Stops Work on Cell Therapy Cure for Type 1 Diabetes
Novo Nordisk A/S cut its cell therapy division, which has been trying to find a cure for type…
Stock market today: Live updates
Traders work on the floor of the New York Stock Exchange. NYSE The S&P 500 and Nasdaq Composite…
Novo Nordisk to buy Akero Therapeutics
A view of the logo of Novo Nordisk at the company’s office in Bagsvaerd, on the outskirts of…